Definitive Healthcare (DH) Stock: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$1.05
0.02 (1.94%)
β²
5d:
+0.96%
30d:
+61.49%
90d:
+23.67%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: DH is 15.4% above its trading range ($0.91). Market expects -2.9% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: DH is 15.4% above its trading range ($0.91). Market expects -2.9% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $1.05, which is considered extended relative to its 30-day fair value range of $0.63 to $0.91. The stock's valuation (Forward PE: 5.5) is in line with its historical norms (6.0). Remarkably, the market is currently pricing in an annual earnings decline of 2.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DH is in a downtrend. Immediate support is located at $0.76, while resistance sits at $1.22.
Market Sentiment: DH scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.90 (+84.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DH is in a downtrend. Immediate support is located at $0.76, while resistance sits at $1.22.
Market Sentiment: DH scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.90 (+84.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.63 -
$0.91
Company Quality Score
29/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
19.0%
All Signals
- BEARISH: Price significantly overextended (+15.4% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 84.5% below Wall St target ($1.90)
- WARNING: Composite score 29/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.63 -
$0.91
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.76
Resistance Level
$1.22
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.52
Wall Street Target
$1.90
(+84.5%)
Revenue Growth (YoY)
-9.1%
Profit Margin
-72.3%
Valuation Discount vs History
-2.9% cheaper
PE vs Historical
5.5 vs 6.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.9%
(market-implied from PE analysis)
1-Year Target
$1.00
(-3%)
2-Year Target
$0.97
(-6%)
3-Year Target
$0.94
(-9%)
3-Yr Target (if PE normalizes)
(PE: 6β6)
$1.02
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: -4.2%)
$3.31
(+222%)
Base:
(SPY PE: 5.5, Growth: -4.2%)
$0.91
(-12%)
Bear:
(PE: 4.7, Growth: -4.2%)
$0.77
(-25%)
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.5 to 6.0
Stabilization Target:
$1.12
(+8.7%)
PE Expansion Potential:
+8.7%
Share & Embed Analysis
Last updated: September 11, 2026 4:15 PM ET
Data refreshes hourly during market hours. Next update: 5:15 PM
Data refreshes hourly during market hours. Next update: 5:15 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$294 | 39 SELL |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 42 HOLD |
|
GEHC
GE HealthCare Technologi⦠|
STRONG BUY
21 analysts |
$90 | 49 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
WAY
Waystar Holding Corp. Co⦠|
STRONG BUY
13 analysts |
$33 | 45 HOLD |